Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1940 1
1945 1
1947 4
1948 2
1950 1
1951 4
1952 1
1953 2
1954 6
1955 1
1956 1
1958 4
1961 2
1962 2
1963 6
1964 1
1965 2
1966 3
1967 3
1968 4
1969 1
1970 4
1971 2
1972 2
1973 1
1975 1
1977 2
1982 7
1983 3
1984 1
1985 6
1986 1
1991 3
1993 1
1994 1
1995 2
1996 3
1997 3
1998 3
1999 2
2000 2
2001 2
2002 4
2003 4
2004 6
2005 6
2006 4
2007 5
2008 9
2009 4
2010 5
2011 5
2012 10
2013 8
2014 4
2015 8
2016 15
2017 12
2018 12
2019 15
2020 24
2021 19
2022 19
2023 19
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

295 results

Results by year

Filters applied: . Clear all
Page 1
British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults.
Dhar A, Haboubi HN, Attwood SE, Auth MKH, Dunn JM, Sweis R, Morris D, Epstein J, Novelli MR, Hunter H, Cordell A, Hall S, Hayat JO, Kapur K, Moore AR, Read C, Sami SS, Turner PJ, Trudgill NJ. Dhar A, et al. Among authors: hunter h. Gut. 2022 Aug;71(8):1459-1487. doi: 10.1136/gutjnl-2022-327326. Epub 2022 May 23. Gut. 2022. PMID: 35606089 Free PMC article.
Vulvar itch.
Alani A, McDonald L, Abdelrahman W, Hunter HL. Alani A, et al. Among authors: hunter hl. BMJ. 2019 Feb 7;364:l83. doi: 10.1136/bmj.l83. BMJ. 2019. PMID: 30733221 No abstract available.
Megestrol acetate.
Canetta R, Florentine S, Hunter H, Lenaz L. Canetta R, et al. Among authors: hunter h. Cancer Treat Rev. 1983 Sep;10(3):141-57. doi: 10.1016/0305-7372(83)90029-4. Cancer Treat Rev. 1983. PMID: 6352021 Review. No abstract available.
Characterisation of C101248: A novel selective THIK-1 channel inhibitor for the modulation of microglial NLRP3-inflammasome.
Ossola B, Rifat A, Rowland A, Hunter H, Drinkall S, Bender C, Hamlischer M, Teall M, Burley R, Barker DF, Cadwalladr D, Dickson L, Lawrence JMK, Harvey JRM, Lizio M, Xu X, Kavanagh E, Cheung T, Sheardown S, Lawrence CB, Harte M, Brough D, Madry C, Matthews K, Doyle K, Page K, Powell J, Brice NL, Bürli RW, Carlton MB, Dawson LA. Ossola B, et al. Among authors: hunter h. Neuropharmacology. 2023 Feb 15;224:109330. doi: 10.1016/j.neuropharm.2022.109330. Epub 2022 Nov 12. Neuropharmacology. 2023. PMID: 36375694 Free PMC article.
Portable point-of-care diagnostic devices: an updated review.
Shu T, Hunter H, Zhou Z, Sun Y, Cheng X, Ma J, Su L, Zhang X, Serpe MJ. Shu T, et al. Among authors: hunter h. Anal Methods. 2021 Nov 25;13(45):5418-5435. doi: 10.1039/d1ay01643a. Anal Methods. 2021. PMID: 34787609 Review.
Reopening the case for case reports.
Cotter C, Maybury C, Hunter HJA. Cotter C, et al. Among authors: hunter hja. Br J Dermatol. 2020 Jan;182(1):3-4. doi: 10.1111/bjd.18464. Br J Dermatol. 2020. PMID: 31894875 No abstract available.
Food avoidance strategies in eosinophilic oesophagitis.
Cianferoni A, Shuker M, Brown-Whitehorn T, Hunter H, Venter C, Spergel JM. Cianferoni A, et al. Among authors: hunter h. Clin Exp Allergy. 2019 Mar;49(3):269-284. doi: 10.1111/cea.13360. Clin Exp Allergy. 2019. PMID: 30714219 Review.
The value of case reports in pharmacovigilance.
Garcia-Doval I, Segovia E, Hunter H, Frew J, Naldi L. Garcia-Doval I, et al. Among authors: hunter h. Br J Dermatol. 2020 Nov;183(5):795-796. doi: 10.1111/bjd.19504. Br J Dermatol. 2020. PMID: 33135791 No abstract available.
Maintained improvement in physician- and patient-reported outcomes with baricitinib in adults with moderate-to-severe atopic dermatitis who were treated for up to 104 weeks in a randomized trial.
Thyssen JP, Werfel T, Barbarot S, Hunter HJA, Pierce E, Sun L, Cirri L, Buchanan AS, Lu N, Wollenberg A. Thyssen JP, et al. Among authors: hunter hja. J Dermatolog Treat. 2023 Dec;34(1):2190430. doi: 10.1080/09546634.2023.2190430. J Dermatolog Treat. 2023. PMID: 36912484 Free article. Clinical Trial.
295 results